92 results
8-K
EX-10.3
2q045 obl3rpkt7ax
11 Mar 24
Dyadic Announces Closing of Private Placement of
8:45am
8-K
EX-10.1
fxr9 ecwoyasx
11 Mar 24
Dyadic Announces Closing of Private Placement of
8:45am
8-K
EX-10.1
dhhp53rpwa6let1o8uh
12 Apr 23
Dyadic Announces Expanded Licensing Agreement to Develop and Commercialize Vaccines and Biologics for African Continent
8:30am
8-K
EX-10.1
2ndtnx 6yctwp1lydh
11 May 22
Dyadic Announces Research, License and Collaboration for the Manufacture of
9:57am
8-K
EX-10.1
y6ugv u5bt9yh19q7
17 Dec 21
Dyadic Announces Research, License and Collaboration Agreement with Janssen
7:10am
8-K
6ciuw8nyfis
9 Nov 21
Dyadic Appoints Chief Business Officer to Executive Leadership Team
8:40am
8-K
EX-10.1
5erk6c68 t98f
9 Nov 21
Dyadic Appoints Chief Business Officer to Executive Leadership Team
8:40am